Establishing translational performance standards for TB therapy using rifampicin-based regimens in a male and female high-burden murine model. [PDF]
Cummings JE+5 more
europepmc +1 more source
Clinical Characteristics of Parkinsonism in HTLV‐1‐Associated Myelopathy
ABSTRACT Objective Human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the classic neurological manifestation of HTLV‐1 infection; however, this virus has also been associated with other neurological disorders. Concurrent parkinsonism is relatively rare and presents diagnostic challenges.
Mika Dozono+8 more
wiley +1 more source
I want to stay and excel: a field theory perspective on the career development of male nurses. [PDF]
Wu Q+9 more
europepmc +1 more source
Evolution and Adaptation in the Palpus of Male Spiders.
Jas. A. Nelson
openalex +2 more sources
The Workers of Vespa Carolina Dr. Resemble in Coloration the Males. A Correction [PDF]
C. H. Turner
openalex +1 more source
Long‐Term Temporal Profile of Motor Recovery After Intracerebral Hemorrhage
ABSTRACT Objective Limited data is available to describe the temporal profile of long‐term recovery over 1 year after the stroke in patients with spontaneous intracerebral hemorrhage (ICH). Methods A registered multicentral cohort was conducted to consecutively include non‐herniated supratentorial ICH patients from November 2013 to January 2023 ...
Yan Zheng+24 more
wiley +1 more source
Delivering a new undergraduate module in Asset Management [PDF]
Crossley, Andy, Male, Steven
core +1 more source
Personalized In Vitro Fertilization Protocols in Premature Ovarian Insufficiency and Male-Factor Infertility: A Case Series. [PDF]
Heriyanto A+3 more
europepmc +1 more source
In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock+8 more
wiley +1 more source